PubMed

Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection.

Cummings JF, Spring MD, Schwenk RJ, Ockenhouse CF, Kester KE, Polhemus ME, Walsh DS, Yoon IK, Prosperi C, Juompan LY, Lanar DE, Krzych U, Hall BT, Ware LA, Stewart VA, Williams J, Dowler M, Nielsen RK, Hillier CJ, Giersing BK, Dubovsky F, Malkin E, Tucker K, Dubois MC, Cohen JD, Ballou WR, Jr DG.

Vaccine. 2009 Sep 5. [Epub ahead of print]PMID: 19737527 [PubMed - as supplied by publisher]Related articles

Evaluation of RTS,S/AS02A and RTS,S/AS01B in adults in a high malaria transmission area.

Polhemus ME, Remich SA, Ogutu BR, Waitumbi JN, Otieno L, Apollo S, Cummings JF, Kester KE, Ockenhouse CF, Stewart A, Ofori-Anyinam O, Ramboer I, Cahill CP, Lievens M, Dubois MC, Demoitie MA, Leach A, Cohen J, Ballou RW, Heppner GD Jr.

PLoS One. 2009 Jul 31;4(7):e6465.PMID: 19649245 [PubMed - indexed for MEDLINE]Related articlesFree article

Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection.

Kester KE, Cummings JF, Ofori-Anyinam O, Ockenhouse CF, Krzych U, Moris P, Schwenk R, Nielsen RA, Debebe Z, Pinelis E, Juompan L, Williams J, Dowler M, Stewart VA, Wirtz RA, Dubois MC, Lievens M, Cohen J, Ballou WR, Heppner DG Jr; RTS,S Vaccine Evaluation Group.

J Infect Dis. 2009 Aug 1;200(3):337-46.PMID: 19569965 [PubMed - indexed for MEDLINE]Related articles

Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A.

Spring MD, Cummings JF, Ockenhouse CF, Dutta S, Reidler R, Angov E, Bergmann-Leitner E, Stewart VA, Bittner S, Juompan L, Kortepeter MG, Nielsen R, Krzych U, Tierney E, Ware LA, Dowler M, Hermsen CC, Sauerwein RW, de Vlas SJ, Ofori-Anyinam O, Lanar DE, Williams JL, Kester KE, Tucker K, Shi M, Malkin E, Long C, Diggs CL, Soisson L, Dubois MC, Ballou WR, Cohen J, Heppner DG Jr.

PLoS One. 2009;4(4):e5254. Epub 2009 Apr 23.PMID: 19390585 [PubMed - indexed for MEDLINE]Related articlesFree article

Adenovirus 5 and 35 vectors expressing Plasmodium falciparum circumsporozoite surface protein elicit potent antigen-specific cellular IFN-gamma and antibody responses in mice.

Shott JP, McGrath SM, Pau MG, Custers JH, Ophorst O, Demoitié MA, Dubois MC, Komisar J, Cobb M, Kester KE, Dubois P, Cohen J, Goudsmit J, Heppner DG, Stewart VA.

Vaccine. 2008 Jun 2;26(23):2818-23. Epub 2008 Apr 16.PMID: 18455276 [PubMed - indexed for MEDLINE]Related articles

Phase 2a trial of 0, 1, and 3 month and 0, 7, and 28 day immunization schedules of malaria vaccine RTS,S/AS02 in malaria-naïve adults at the Walter Reed Army Institute of Research.

Kester KE, Cummings JF, Ockenhouse CF, Nielsen R, Hall BT, Gordon DM, Schwenk RJ, Krzych U, Holland CA, Richmond G, Dowler MG, Williams J, Wirtz RA, Tornieporth N, Vigneron L, Delchambre M, Demoitie MA, Ballou WR, Cohen J, Heppner DG Jr; RTS,S Malaria Vaccine Evaluation Group.

Vaccine. 2008 Apr 24;26(18):2191-202. Epub 2008 Mar 13.PMID: 18387719 [PubMed - indexed for MEDLINE]Related articles

A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-naïve adults.

Kester KE, McKinney DA, Tornieporth N, Ockenhouse CF, Heppner DG Jr, Hall T, Wellde BT, White K, Sun P, Schwenk R, Krzych U, Delchambre M, Voss G, Dubois MC, Gasser RA Jr, Dowler MG, O'Brien M, Wittes J, Wirtz R, Cohen J, Ballou WR; RTS,S Malaria Vaccine Evaluation Group.

Vaccine. 2007 Jul 20;25(29):5359-66. Epub 2007 May 30.PMID: 17574311 [PubMed - indexed for MEDLINE]Related articles

Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research.

Polhemus ME, Magill AJ, Cummings JF, Kester KE, Ockenhouse CF, Lanar DE, Dutta S, Barbosa A, Soisson L, Diggs CL, Robinson SA, Haynes JD, Stewart VA, Ware LA, Brando C, Krzych U, Bowden RA, Cohen JD, Dubois MC, Ofori-Anyinam O, De-Kock E, Ballou WR, Heppner DG Jr.

Vaccine. 2007 May 22;25(21):4203-12. Epub 2007 Mar 26.PMID: 17442466 [PubMed - indexed for MEDLINE]Related articles

Common and divergent immune response signaling pathways discovered in peripheral blood mononuclear cell gene expression patterns in presymptomatic and clinically apparent malaria.

Ockenhouse CF, Hu WC, Kester KE, Cummings JF, Stewart A, Heppner DG, Jedlicka AE, Scott AL, Wolfe ND, Vahey M, Burke DS.

Infect Immun. 2006 Oct;74(10):5561-73.PMID: 16988231 [PubMed - indexed for MEDLINE]Related articlesFree article

Cutaneous delayed-type hypersensitivity (DTH) in a multi-formulation comparator trial of the anti-falciparum malaria vaccine candidate RTS,S in rhesus macaques.

Stewart VA, Walsh DS, McGrath SM, Kester KE, Cummings JF, Voss G, Delchambre M, Garçon N, Cohen JD, Heppner DG Jr.

Vaccine. 2006 Oct 30;24(42-43):6493-502. Epub 2006 Jul 5.PMID: 16911849 [PubMed - indexed for MEDLINE]Related articles

Pre-clinical evaluation of new adjuvant formulations to improve the immunogenicity of the malaria vaccine RTS,S/AS02A.

Stewart VA, McGrath SM, Walsh DS, Davis S, Hess AS, Ware LA, Kester KE, Cummings JF, Burge JR, Voss G, Delchambre M, Garçon N, Tang DB, Cohen JD, Heppner DG Jr.

Vaccine. 2006 Oct 30;24(42-43):6483-92. Epub 2006 Jul 3.PMID: 16904798 [PubMed - indexed for MEDLINE]Related articles

Phase 1 safety and immunogenicity trial of malaria vaccine RTS,S/AS02A in adults in a hyperendemic region of western Kenya.

Stoute JA, Heppner DG Jr, Mason CJ, Siangla J, Opollo MO, Kester KE, Vigneron L, Voss G, Walter MJ, Tornieporth N, Cohen JD, Ballou WR.

Am J Trop Med Hyg. 2006 Jul;75(1):166-70.PMID: 16837726 [PubMed - indexed for MEDLINE]Related articlesFree article

Heterologous prime-boost immunization in rhesus macaques by two, optimally spaced particle-mediated epidermal deliveries of Plasmodium falciparum circumsporozoite protein-encoding DNA, followed by intramuscular RTS,S/AS02A.

Walsh DS, Gettayacamin M, Leitner WW, Lyon JA, Stewart VA, Marit G, Pichyangkul S, Gosi P, Tongtawe P, Kester KE, Holland CA, Kolodny N, Cohen J, Voss G, Ballou WR, Heppner DG Jr.

Vaccine. 2006 May 8;24(19):4167-78. Epub 2006 Mar 6.PMID: 16574282 [PubMed - indexed for MEDLINE]Related articles

Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya.

Stoute JA, Gombe J, Withers MR, Siangla J, McKinney D, Onyango M, Cummings JF, Milman J, Tucker K, Soisson L, Stewart VA, Lyon JA, Angov E, Leach A, Cohen J, Kester KE, Ockenhouse CF, Holland CA, Diggs CL, Wittes J, Heppner DG Jr; MSP-1 Malaria Vaccine Working Group.

Vaccine. 2007 Jan 2;25(1):176-84. Epub 2005 Dec 7.PMID: 16388879 [PubMed - indexed for MEDLINE]Related articles

Phase I safety and immunogenicity trial of FMP1/AS02A, a Plasmodium falciparum MSP-1 asexual blood stage vaccine.

Ockenhouse CF, Angov E, Kester KE, Diggs C, Soisson L, Cummings JF, Stewart AV, Palmer DR, Mahajan B, Krzych U, Tornieporth N, Delchambre M, Vanhandenhove M, Ofori-Anyinam O, Cohen J, Lyon JA, Heppner DG; MSP-1 Working Group.

Vaccine. 2006 Apr 5;24(15):3009-17. Epub 2005 Nov 28.PMID: 16356603 [PubMed - indexed for MEDLINE]Related articles

Safety and immunogenicty of RTS,S/AS02A candidate malaria vaccine in Gambian children.

Bojang KA, Olodude F, Pinder M, Ofori-Anyinam O, Vigneron L, Fitzpatrick S, Njie F, Kassanga A, Leach A, Milman J, Rabinovich R, McAdam KP, Kester KE, Heppner DG, Cohen JD, Tornieporth N, Milligan PJ.

Vaccine. 2005 Jul 14;23(32):4148-57. Epub 2005 Apr 15.PMID: 15964483 [PubMed - indexed for MEDLINE]Related articles

Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.

Heppner DG Jr, Kester KE, Ockenhouse CF, Tornieporth N, Ofori O, Lyon JA, Stewart VA, Dubois P, Lanar DE, Krzych U, Moris P, Angov E, Cummings JF, Leach A, Hall BT, Dutta S, Schwenk R, Hillier C, Barbosa A, Ware LA, Nair L, Darko CA, Withers MR, Ogutu B, Polhemus ME, Fukuda M, Pichyangkul S, Gettyacamin M, Diggs C, Soisson L, Milman J, Dubois MC, Garçon N, Tucker K, Wittes J, Plowe CV, Thera MA, Duombo OK, Pau MG, Goudsmit J, Ballou WR, Cohen J.

Vaccine. 2005 Mar 18;23(17-18):2243-50. Review.PMID: 15755604 [PubMed - indexed for MEDLINE]Related articles

Pre-clinical evaluation of the malaria vaccine candidate P. falciparum MSP1(42) formulated with novel adjuvants or with alum.

Pichyangkul S, Gettayacamin M, Miller RS, Lyon JA, Angov E, Tongtawe P, Ruble DL, Heppner DG Jr, Kester KE, Ballou WR, Diggs CL, Voss G, Cohen JD, Walsh DS.

Vaccine. 2004 Sep 28;22(29-30):3831-40.PMID: 15364429 [PubMed - indexed for MEDLINE]Related articles

Update on the clinical development of candidate malaria vaccines.

Ballou WR, Arevalo-Herrera M, Carucci D, Richie TL, Corradin G, Diggs C, Druilhe P, Giersing BK, Saul A, Heppner DG, Kester KE, Lanar DE, Lyon J, Hill AV, Pan W, Cohen JD.

Am J Trop Med Hyg. 2004 Aug;71(2 Suppl):239-47. Review.PMID: 15331843 [PubMed - indexed for MEDLINE]Related articlesFree article

Safety and immunogenicity of rts,s+trap malaria vaccine, formulated in the as02a adjuvant system, in infant rhesus monkeys.

Walsh DS, Pichyangkul S, Gettayacamin M, Tongtawe P, Siegrist CA, Hansukjariya P, Kester KE, Holland CA, Voss G, Cohen J, Stewart AV, Miller RS, Ballou WR, Heppner DG Jr.

Am J Trop Med Hyg. 2004 May;70(5):499-509.PMID: 15155981 [PubMed - indexed for MEDLINE]Related articlesFree article

Induction in humans of CD8+ and CD4+ T cell and antibody responses by sequential immunization with malaria DNA and recombinant protein.

Wang R, Epstein J, Charoenvit Y, Baraceros FM, Rahardjo N, Gay T, Banania JG, Chattopadhyay R, de la Vega P, Richie TL, Tornieporth N, Doolan DL, Kester KE, Heppner DG, Norman J, Carucci DJ, Cohen JD, Hoffman SL.

J Immunol. 2004 May 1;172(9):5561-9.PMID: 15100299 [PubMed - indexed for MEDLINE]Related articlesFree article

Safety, tolerability, and antibody responses in humans after sequential immunization with a PfCSP DNA vaccine followed by the recombinant protein vaccine RTS,S/AS02A.

Epstein JE, Charoenvit Y, Kester KE, Wang R, Newcomer R, Fitzpatrick S, Richie TL, Tornieporth N, Heppner DG, Ockenhouse C, Majam V, Holland C, Abot E, Ganeshan H, Berzins M, Jones T, Freydberg CN, Ng J, Norman J, Carucci DJ, Cohen J, Hoffman SL.

Vaccine. 2004 Apr 16;22(13-14):1592-603.PMID: 15068840 [PubMed - indexed for MEDLINE]Related articles

A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease.

Reece WH, Pinder M, Gothard PK, Milligan P, Bojang K, Doherty T, Plebanski M, Akinwunmi P, Everaere S, Watkins KR, Voss G, Tornieporth N, Alloueche A, Greenwood BM, Kester KE, McAdam KP, Cohen J, Hill AV.

Nat Med. 2004 Apr;10(4):406-10. Epub 2004 Mar 14.PMID: 15034567 [PubMed - indexed for MEDLINE]Related articles

Protective immunity induced with malaria vaccine, RTS,S, is linked to Plasmodium falciparum circumsporozoite protein-specific CD4+ and CD8+ T cells producing IFN-gamma.

Sun P, Schwenk R, White K, Stoute JA, Cohen J, Ballou WR, Voss G, Kester KE, Heppner DG, Krzych U.

J Immunol. 2003 Dec 15;171(12):6961-7.PMID: 14662904 [PubMed - indexed for MEDLINE]Related articlesFree article

Devices for rapid diagnosis of Malaria: evaluation of prototype assays that detect Plasmodium falciparum histidine-rich protein 2 and a Plasmodium vivax-specific antigen.

Forney JR, Wongsrichanalai C, Magill AJ, Craig LG, Sirichaisinthop J, Bautista CT, Miller RS, Ockenhouse CF, Kester KE, Aronson NE, Andersen EM, Quino-Ascurra HA, Vidal C, Moran KA, Murray CK, DeWitt CC, Heppner DG, Kain KC, Ballou WR, Gasser RA Jr.

J Clin Microbiol. 2003 Jun;41(6):2358-66.PMID: 12791849 [PubMed - indexed for MEDLINE]Related articlesFree article

Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans.

McConkey SJ, Reece WH, Moorthy VS, Webster D, Dunachie S, Butcher G, Vuola JM, Blanchard TJ, Gothard P, Watkins K, Hannan CM, Everaere S, Brown K, Kester KE, Cummings J, Williams J, Heppner DG, Pathan A, Flanagan K, Arulanantham N, Roberts MT, Roy M, Smith GL, Schneider J, Peto T, Sinden RE, Gilbert SC, Hill AV.

Nat Med. 2003 Jun;9(6):729-35. Epub 2003 May 25.PMID: 12766765 [PubMed - indexed for MEDLINE]Related articles

Opsonization by antigen-specific antibodies as a mechanism of protective immunity induced by Plasmodium falciparum circumsporozoite protein-based vaccine.

Schwenk R, Asher LV, Chalom I, Lanar D, Sun P, White K, Keil D, Kester KE, Stoute J, Heppner DG, Krzych U.

Parasite Immunol. 2003 Jan;25(1):17-25.PMID: 12753434 [PubMed - indexed for MEDLINE]Related articles

Development and pre-clinical analysis of a Plasmodium falciparum Merozoite Surface Protein-1(42) malaria vaccine.

Angov E, Aufiero BM, Turgeon AM, Van Handenhove M, Ockenhouse CF, Kester KE, Walsh DS, McBride JS, Dubois MC, Cohen J, Haynes JD, Eckels KH, Heppner DG, Ballou WR, Diggs CL, Lyon JA.

Mol Biochem Parasitol. 2003 May;128(2):195-204.PMID: 12742586 [PubMed - indexed for MEDLINE]Related articles

Pre-erythrocytic malaria vaccines to prevent Plasmodium falciparum malaria.

Ballou WR, Kester KE, Heppner DG.

Chem Immunol. 2002;80:253-61. Review. No abstract available. PMID: 12058643 [PubMed - indexed for MEDLINE]Related articles

Induction of T helper type 1 and 2 responses to 19-kilodalton merozoite surface protein 1 in vaccinated healthy volunteers and adults naturally exposed to malaria.

Lee EA, Palmer DR, Flanagan KL, Reece WH, Odhiambo K, Marsh K, Pinder M, Gravenor MB, Keitel WA, Kester KE, Diggs C, Kaslow D, Apostolopoulos V, Ballou WR, Hill AV, Krzych U, Plebanski M.

Infect Immun. 2002 Mar;70(3):1417-21.PMID: 11854228 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial.

Bojang KA, Milligan PJ, Pinder M, Vigneron L, Alloueche A, Kester KE, Ballou WR, Conway DJ, Reece WH, Gothard P, Yamuah L, Delchambre M, Voss G, Greenwood BM, Hill A, McAdam KP, Tornieporth N, Cohen JD, Doherty T; RTS, S Malaria Vaccine Trial Team.

Lancet. 2001 Dec 8;358(9297):1927-34.PMID: 11747915 [PubMed - indexed for MEDLINE]Related articles

Causal prophylactic efficacy of atovaquone-proguanil (Malarone) in a human challenge model.

Berman JD, Nielsen R, Chulay JD, Dowler M, Kain KC, Kester KE, Williams J, Whelen AC, Shmuklarsky MJ.

Trans R Soc Trop Med Hyg. 2001 Jul-Aug;95(4):429-32.PMID: 11579890 [PubMed - indexed for MEDLINE]Related articles

New World monkey efficacy trials for malaria vaccine development: critical path or detour?

Heppner DG, Cummings JF, Ockenhouse C, Kester KE, Lyon JA, Gordon DM.

Trends Parasitol. 2001 Sep;17(9):419-25.PMID: 11530353 [PubMed - indexed for MEDLINE]Related articles

Malaria rapid diagnostic devices: performance characteristics of the ParaSight F device determined in a multisite field study.

Forney JR, Magill AJ, Wongsrichanalai C, Sirichaisinthop J, Bautista CT, Heppner DG, Miller RS, Ockenhouse CF, Gubanov A, Shafer R, DeWitt CC, Quino-Ascurra HA, Kester KE, Kain KC, Walsh DS, Ballou WR, Gasser RA Jr.

J Clin Microbiol. 2001 Aug;39(8):2884-90.PMID: 11474008 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy of recombinant circumsporozoite protein vaccine regimens against experimental Plasmodium falciparum malaria.

Kester KE, McKinney DA, Tornieporth N, Ockenhouse CF, Heppner DG, Hall T, Krzych U, Delchambre M, Voss G, Dowler MG, Palensky J, Wittes J, Cohen J, Ballou WR; RTS,S Malaria Vaccine Evaluation Group.

J Infect Dis. 2001 Feb 15;183(4):640-7. Epub 2001 Jan 24.PMID: 11170991 [PubMed - indexed for MEDLINE]Related articles

Organism responsible for nodular cutaneous microsporidiosis in a patient with AIDS.

Kester KE, Visvesara GS, McEvoy P.

Ann Intern Med. 2000 Dec 5;133(11):925. No abstract available. PMID: 11103074 [PubMed - indexed for MEDLINE]Related articlesFree article

Malaria vaccines: triumphs or tribulations?

Ballou WR, Kester KE, Stoute JA, Heppner DG.

Parassitologia. 1999 Sep;41(1-3):403-8. Review.PMID: 10697893 [PubMed - indexed for MEDLINE]Related articles

A phase I safety and immunogenicity trial with the candidate malaria vaccine RTS,S/SBAS2 in semi-immune adults in The Gambia.

Doherty JF, Pinder M, Tornieporth N, Carton C, Vigneron L, Milligan P, Ballou WR, Holland CA, Kester KE, Voss G, Momin P, Greenwood BM, McAdam KP, Cohen J.

Am J Trop Med Hyg. 1999 Dec;61(6):865-8.PMID: 10674660 [PubMed - indexed for MEDLINE]Related articlesFree article

Phase I trial of two recombinant vaccines containing the 19kd carboxy terminal fragment of Plasmodium falciparum merozoite surface protein 1 (msp-1(19)) and T helper epitopes of tetanus toxoid.

Keitel WA, Kester KE, Atmar RL, White AC, Bond NH, Holland CA, Krzych U, Palmer DR, Egan A, Diggs C, Ballou WR, Hall BF, Kaslow D.

Vaccine. 1999 Oct 14;18(5-6):531-9.PMID: 10519944 [PubMed - indexed for MEDLINE]Related articles

Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine.

Lalvani A, Moris P, Voss G, Pathan AA, Kester KE, Brookes R, Lee E, Koutsoukos M, Plebanski M, Delchambre M, Flanagan KL, Carton C, Slaoui M, Van Hoecke C, Ballou WR, Hill AV, Cohen J.

J Infect Dis. 1999 Nov;180(5):1656-64.PMID: 10515829 [PubMed - indexed for MEDLINE]Related articles

Primaquine prophylaxis against malaria.

Heppner DG Jr, Gasser RA Jr, Kester KE.

Ann Intern Med. 1999 Mar 16;130(6):536; author reply 536-7. No abstract available. PMID: 10075625 [PubMed - indexed for MEDLINE]Related articlesFree article

Passive transfer of growth-inhibitory antibodies raised against yeast-expressed recombinant Plasmodium falciparum merozoite surface protein-1(19).

Gozalo A, Lucas C, Cachay M, Wellde BT, Hall T, Bell B, Wood J, Watts D, Wooster M, Lyon JA, Moch JK, Haynes JD, Williams JS, Holland C, Watson E, Kester KE, Kaslow DC, Ballou WR.

Am J Trop Med Hyg. 1998 Dec;59(6):991-7.PMID: 9886211 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-term efficacy and immune responses following immunization with the RTS,S malaria vaccine.

Stoute JA, Kester KE, Krzych U, Wellde BT, Hall T, White K, Glenn G, Ockenhouse CF, Garcon N, Schwenk R, Lanar DE, Sun P, Momin P, Wirtz RA, Golenda C, Slaoui M, Wortmann G, Holland C, Dowler M, Cohen J, Ballou WR.

J Infect Dis. 1998 Oct;178(4):1139-44.PMID: 9806046 [PubMed - indexed for MEDLINE]Related articles

Nodular cutaneous microsporidiosis in a patient with AIDS and successful treatment with long-term oral clindamycin therapy.

Kester KE, Turiansky GW, McEvoy PL.

Ann Intern Med. 1998 Jun 1;128(11):911-4.PMID: 9634430 [PubMed - indexed for MEDLINE]Related articlesFree article

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group.

Stoute JA, Slaoui M, Heppner DG, Momin P, Kester KE, Desmons P, Wellde BT, Garçon N, Krzych U, Marchand M.

N Engl J Med. 1997 Jan 9;336(2):86-91.PMID: 8988885 [PubMed - indexed for MEDLINE]Related articlesFree article

Meningitis and hepatitis complicating intravenous immunoglobulin therapy.

Shorr AF, Kester KE.

Ann Pharmacother. 1996 Oct;30(10):1115-6.PMID: 8893119 [PubMed - indexed for MEDLINE]Related articles

Granulomatous Pneumocystis carinii pneumonia in patients with low-grade lymphoid malignancies: a diagnostic dilemma.

Kester KE, Byrd JC, Rearden TP, Zacher LL, Cragun WH, Hargis JB.

Clin Infect Dis. 1996 Jun;22(6):1111-2. No abstract available. PMID: 8783726 [PubMed - indexed for MEDLINE]Related articles

Opportunistic pulmonary infections with fludarabine in previously treated patients with low-grade lymphoid malignancies: a role for Pneumocystis carinii pneumonia prophylaxis.

Byrd JC, Hargis JB, Kester KE, Hospenthal DR, Knutson SW, Diehl LF.

Am J Hematol. 1995 Jun;49(2):135-42.PMID: 7771465 [PubMed - indexed for MEDLINE]Related articles

Imaging case of the month. Parenchymal neurocysticercosis.

Kester KE.

Md Med J. 1993 Jul;42(7):677-9. No abstract available. PMID: 8412529 [PubMed - indexed for MEDLINE]Related articles